Medtronic stentless Freestyle® porcine aortic valve replacement
| dc.contributor.author | Ennker, J. | |
| dc.contributor.author | Albert, A. | |
| dc.contributor.author | Florath, Ines | |
| dc.date.accessioned | 2017-01-30T13:27:36Z | |
| dc.date.available | 2017-01-30T13:27:36Z | |
| dc.date.created | 2016-09-12T08:37:05Z | |
| dc.date.issued | 2010 | |
| dc.identifier.citation | Ennker, J. and Albert, A. and Florath, I. 2010. Medtronic stentless Freestyle® porcine aortic valve replacement. In Aortic Root Surgery: The Biological Solution, 366-385: Steinkopff. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/31831 | |
| dc.identifier.doi | 10.1007/978-3-7985-1869-8_26 | |
| dc.description.abstract |
Biological heart valve prostheses offer the opportunity of avoiding the risk of thromboembolic and hemorrhagic complications due to anticoagulation therapy. Current indications recommend a bioprosthesis for aortic valve replacement in patients of any age, who will not take warfarin or who have major medical contraindications to anticoagulation therapy (Class I), in patients older than 65 years without risk factors for thromboembolism (Class IIa) and in patients under 65 years for lifestyle considerations after detailed discussion of the risks of anticoagulation versus the likelihood of a second valve replacement [1]. © 2010 Steinkopff. | |
| dc.publisher | Steinkopff | |
| dc.title | Medtronic stentless Freestyle® porcine aortic valve replacement | |
| dc.type | Book Chapter | |
| dcterms.source.startPage | 366 | |
| dcterms.source.endPage | 385 | |
| dcterms.source.title | Aortic Root Surgery: The Biological Solution | |
| dcterms.source.isbn | 9783798518681 | |
| curtin.department | Epidemiology and Biostatistics | |
| curtin.accessStatus | Fulltext not available |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||